| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.95B | 1.81B | 1.91B | 1.74B | 1.32B |
| Gross Profit | 632.50M | 599.60M | 568.80M | 523.00M | 422.90M |
| EBITDA | 158.70M | 147.80M | 124.10M | 110.60M | 101.30M |
| Net Income | 57.60M | 46.30M | 35.90M | 32.30M | 25.40M |
Balance Sheet | |||||
| Total Assets | 1.27B | 1.20B | 1.30B | 1.34B | 1.29B |
| Cash, Cash Equivalents and Short-Term Investments | 81.80M | 57.30M | 116.50M | 99.60M | 119.10M |
| Total Debt | 207.70M | 250.30M | 315.50M | 327.60M | 361.80M |
| Total Liabilities | 780.70M | 754.50M | 837.90M | 873.10M | 868.30M |
| Stockholders Equity | 492.00M | 450.20M | 459.80M | 465.60M | 423.20M |
Cash Flow | |||||
| Free Cash Flow | 122.20M | 79.60M | 61.60M | 42.90M | 62.50M |
| Operating Cash Flow | 165.60M | 112.00M | 99.00M | 92.90M | 102.70M |
| Investing Cash Flow | -43.40M | -31.70M | -31.30M | -50.00M | -17.60M |
| Financing Cash Flow | -85.50M | -98.70M | -81.50M | -69.40M | -58.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.74B | 8.36 | 15.07% | 2.06% | 6.96% | 28.47% | |
76 Outperform | £1.56B | 8.95 | 10.71% | 1.62% | 0.50% | 20.52% | |
71 Outperform | £432.88M | 11.83 | 12.72% | 7.01% | 8.58% | -15.81% | |
70 Outperform | £1.91B | 17.26 | 12.23% | 0.79% | 7.74% | 30.09% | |
69 Neutral | £12.94B | 15.47 | 9.22% | 2.98% | -3.06% | -26.93% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |